- Home
- AAPG vs TAC Comparison
AAPG vs TAC Comparison
Compare AAPG & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- TAC
- Stock Information
- Founded
- AAPG 2009
- TAC 1909
- Country
- AAPG China
- TAC Canada
- Employees
- AAPG N/A
- TAC N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- TAC Electric Utilities: Central
- Sector
- AAPG Health Care
- TAC Utilities
- Exchange
- AAPG Nasdaq
- TAC Nasdaq
- Market Cap
- AAPG 3.6B
- TAC 4.3B
- IPO Year
- AAPG 2025
- TAC N/A
- Fundamental
- Price
- AAPG $39.38
- TAC $14.48
- Analyst Decision
- AAPG Buy
- TAC Buy
- Analyst Count
- AAPG 1
- TAC 3
- Target Price
- AAPG N/A
- TAC $19.83
- AVG Volume (30 Days)
- AAPG 9.1K
- TAC 1.2M
- Earning Date
- AAPG 11-06-2025
- TAC 11-04-2025
- Dividend Yield
- AAPG N/A
- TAC 1.24%
- EPS Growth
- AAPG N/A
- TAC N/A
- EPS
- AAPG N/A
- TAC N/A
- Revenue
- AAPG $54,524,554.00
- TAC $1,838,165,207.00
- Revenue This Year
- AAPG N/A
- TAC N/A
- Revenue Next Year
- AAPG $368.64
- TAC N/A
- P/E Ratio
- AAPG N/A
- TAC N/A
- Revenue Growth
- AAPG N/A
- TAC N/A
- 52 Week Low
- AAPG $16.50
- TAC $7.82
- 52 Week High
- AAPG $48.45
- TAC $14.90
- Technical
- Relative Strength Index (RSI)
- AAPG 49.07
- TAC 76.42
- Support Level
- AAPG $37.20
- TAC $13.40
- Resistance Level
- AAPG $40.48
- TAC $13.90
- Average True Range (ATR)
- AAPG 0.75
- TAC 0.37
- MACD
- AAPG 0.20
- TAC 0.05
- Stochastic Oscillator
- AAPG 67.07
- TAC 80.28
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.